{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:54:45Z","timestamp":1790895285250,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":85,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012127","name":"Augusta University","doi-asserted-by":"publisher","award":["GCCSONG00009"],"award-info":[{"award-number":["GCCSONG00009"]}],"id":[{"id":"10.13039\/100012127","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK105565"],"award-info":[{"award-number":["DK105565"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["3R01CA062130"],"award-info":[{"award-number":["3R01CA062130"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["5R01CA132640"],"award-info":[{"award-number":["5R01CA132640"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Ferroptosis is an iron-dependent form of regulated cell death driven by lipid peroxidation and glutathione (GSH) depletion and represents a therapeutic vulnerability in hepatocellular carcinoma (HCC). While canonical ferroptosis regulation centers on cystine uptake and GPX4-mediated GSH utilization, the endogenous metabolic pathways governing ferroptosis sensitivity in liver tumors remain incompletely understood. Here, using a metabolic-scale CRISPR activation screen integrated with transcriptomic and metabolomic analyses, we identify L-2-hydroxyglutarate dehydrogenase (L2HGDH) as a potent antagonist of ferroptosis in HCC. We demonstrate that L2HGDH is frequently suppressed in liver tumors, leading to pathological accumulation of its substrate L-2-hydroxyglutarate (L2HG). Elevated L2HG sensitizes HCC cells to ferroptosis both in vitro and in vivo. Mechanistically, L2HG acts as a metabolic-epigenetic regulator that inhibits 2-oxoglutarate-dependent dioxygenases, induces histone hypermethylation, and remodels chromatin accessibility to activate an ATF3-dependent transcriptional program. This program induces the glutathione-degrading enzyme CHAC1, thereby accelerating GSH degradation to 5-oxoproline and disrupting redox homeostasis. Notably, L2HG-induced ferroptosis occurs independently of impaired cystine uptake, transsulfuration pathway activity, or increased GPX4-mediated GSH utilization, revealing a non-canonical ferroptosis mechanism driven by enhanced GSH catabolism. Consistent with these findings, genetic targeting of L2HGDH suppresses tumor growth, elevates L2HG levels, enhances GSH degradation, and promotes ferroptosis in HCC xenograft models. Collectively, our study identifies the L2HGDH-L2HG axis as a previously unrecognized metabolic checkpoint controlling ferroptosis sensitivity in liver cancer and uncovers glutathione degradation as a therapeutically exploitable vulnerability for ferroptosis-based treatment strategies in HCC.<\/jats:p>","DOI":"10.1038\/s41419-026-09052-x","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T17:35:59Z","timestamp":1783532159000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["L-2-Hydroxyglutarate sensitizes ferroptosis through ATF3\/CHAC1-mediated glutathione degradation in hepatocellular carcinoma"],"prefix":"10.1038","volume":"17","author":[{"given":"Caixia","family":"Xi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfeng","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Oliaeimotlagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Zhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimya","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5127-9211","authenticated-orcid":false,"given":"Tianxiang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huidong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ande","family":"Satyanarayana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anatolij","family":"Horuzsko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3974-7991","authenticated-orcid":false,"given":"Chunhong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahid F.","family":"Mivechi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7039-4541","authenticated-orcid":false,"given":"Xingguo","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"9052_CR1","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","volume":"31","author":"D Tang","year":"2021","unstructured":"Tang D, Chen X, Kang R, Kroemer G. Ferroptosis: molecular mechanisms and health implications. Cell Res. 2021;31:107\u201325.","journal-title":"Cell Res"},{"key":"9052_CR2","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","volume":"185","author":"BR Stockwell","year":"2022","unstructured":"Stockwell BR. Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications. Cell. 2022;185:2401\u201321.","journal-title":"Cell"},{"key":"9052_CR3","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","volume":"22","author":"G Lei","year":"2022","unstructured":"Lei G, Zhuang L, Gan B. Targeting ferroptosis as a vulnerability in cancer. Nat Rev Cancer. 2022;22:381\u201396.","journal-title":"Nat Rev Cancer"},{"key":"9052_CR4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1146\/annurev-cancerbio-030518-055844","volume":"3","author":"SJ Dixon","year":"2019","unstructured":"Dixon SJ, Stockwell BR. The hallmarks of ferroptosis. Annu Rev Canc Biol. 2019;3:35\u201354.","journal-title":"Annu Rev Canc Biol"},{"key":"9052_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02520-6","volume":"24","author":"Y Wu","year":"2025","unstructured":"Wu Y, Li H, Yue K, Jing C, Duan Y. Ferroptosis in cancer: metabolism, mechanisms and therapeutic prospects. Mol Cancer. 2025;24:303.","journal-title":"Mol Cancer"},{"key":"9052_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1021\/acscentsci.9b01063","volume":"6","author":"VAN Kraft","year":"2020","unstructured":"Kraft VAN, Bezjian CT, Pfeiffer S, Ringelstetter L, Muller C, Zandkarimi F, et al. GTP Cyclohydrolase 1\/tetrahydrobiopterin counteract ferroptosis through lipid remodeling. ACS Cent Sci. 2020;6:41\u201353.","journal-title":"ACS Cent Sci"},{"key":"9052_CR7","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.cmet.2020.12.007","volume":"33","author":"YP Kang","year":"2021","unstructured":"Kang YP, Mockabee-Macias A, Jiang C, Falzone A, Prieto-Farigua N, Stone E, et al. Non-canonical glutamate-cysteine ligase activity protects against ferroptosis. Cell Metab. 2021;33:174\u201389.e7.","journal-title":"Cell Metab"},{"key":"9052_CR8","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abm9427","volume":"8","author":"KM Fujihara","year":"2022","unstructured":"Fujihara KM, Zhang BZ, Jackson TD, Ogunkola MO, Nijagal B, Milne JV, et al. Eprenetapopt triggers ferroptosis, inhibits NFS1 cysteine desulfurase, and synergizes with serine and glycine dietary restriction. Sci Adv. 2022;8:eabm9427.","journal-title":"Sci Adv"},{"key":"9052_CR9","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.cmet.2019.09.009","volume":"30","author":"J Zhu","year":"2019","unstructured":"Zhu J, Berisa M, Schworer S, Qin W, Cross JR, Thompson CB. Transsulfuration activity can support cell growth upon extracellular cysteine limitation. Cell Metab. 2019;30:865\u201376.e5.","journal-title":"Cell Metab"},{"key":"9052_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15109-y","volume":"11","author":"J Cao","year":"2020","unstructured":"Cao J, Chen X, Jiang L, Lu B, Yuan M, Zhu D, et al. DJ-1 suppresses ferroptosis through preserving the activity of S-adenosyl homocysteine hydrolase. Nat Commun. 2020;11:1251.","journal-title":"Nat Commun"},{"key":"9052_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1678-y","volume":"10","author":"S Tsurusaki","year":"2019","unstructured":"Tsurusaki S, Tsuchiya Y, Koumura T, Nakasone M, Sakamoto T, Matsuoka M, et al. Hepatic ferroptosis plays an important role as the trigger for initiating inflammation in nonalcoholic steatohepatitis. Cell Death Dis. 2019;10:449.","journal-title":"Cell Death Dis"},{"key":"9052_CR12","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1182\/blood.2019002907","volume":"136","author":"Y Yu","year":"2020","unstructured":"Yu Y, Jiang L, Wang H, Shen Z, Cheng Q, Zhang P, et al. Hepatic transferrin plays a role in systemic iron homeostasis and liver ferroptosis. Blood. 2020;136:726\u201339.","journal-title":"Blood"},{"key":"9052_CR13","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s41418-022-00941-0","volume":"29","author":"J Chen","year":"2022","unstructured":"Chen J, Li X, Ge C, Min J, Wang F. The multifaceted role of ferroptosis in liver disease. Cell Death Differ. 2022;29:467\u201380.","journal-title":"Cell Death Differ"},{"key":"9052_CR14","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1053\/j.gastro.2024.01.051","volume":"167","author":"JJ Escuder-Rodriguez","year":"2024","unstructured":"Escuder-Rodriguez JJ, Liang D, Jiang X, Sinicrope FA. Ferroptosis: biology and role in gastrointestinal disease. Gastroenterology. 2024;167:231\u201349.","journal-title":"Gastroenterology"},{"key":"9052_CR15","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.cell.2017.03.023","volume":"169","author":"JR Cantor","year":"2017","unstructured":"Cantor JR, Abu-Remaileh M, Kanarek N, Freinkman E, Gao X, Louissaint A Jr., et al. Physiologic medium rewires cellular metabolism and reveals uric acid as an endogenous inhibitor of UMP synthase. Cell. 2017;169:258\u201372.e17.","journal-title":"Cell"},{"key":"9052_CR16","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1016\/j.molcel.2022.05.024","volume":"82","author":"G Unlu","year":"2022","unstructured":"Unlu G, Prizer B, Erdal R, Yeh HW, Bayraktar EC, Birsoy K. Metabolic-scale gene activation screens identify SLCO2B1 as a heme transporter that enhances cellular iron availability. Mol Cell. 2022;82:2832\u201343.e7.","journal-title":"Mol Cell"},{"key":"9052_CR17","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/nbt1210-1248","volume":"28","author":"M Uhlen","year":"2010","unstructured":"Uhlen M, Oksvold P, Fagerberg L, Lundberg E, Jonasson K, Forsberg M, et al. Towards a knowledge-based human protein atlas. Nat Biotechnol. 2010;28:1248\u201350.","journal-title":"Nat Biotechnol"},{"key":"9052_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2021.100300","volume":"2","author":"Z Inde","year":"2021","unstructured":"Inde Z, Rodencal J, Dixon SJ. Quantification of drug-induced fractional killing using high-throughput microscopy. STAR Protoc. 2021;2:100300.","journal-title":"STAR Protoc"},{"key":"9052_CR19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s42003-024-07424-7","volume":"8","author":"C Xi","year":"2025","unstructured":"Xi C, Pang J, Xue W, Cui Y, Jiang N, Zhi W, et al. Transsulfuration pathway activation attenuates oxidative stress and ferroptosis in sickle primary erythroblasts and transgenic mice. Commun Biol. 2025;8:15.","journal-title":"Commun Biol"},{"key":"9052_CR20","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1182\/blood-2023-182389","volume":"142","author":"C Xi","year":"2023","unstructured":"Xi C, Pang J, Zhi W, Chang CS, Siddaramappa U, Shi H, et al. Nrf2 sensitizes ferroptosis through l-2-hydroxyglutarate-mediated chromatin modifications in sickle cell disease. Blood. 2023;142:382\u201396.","journal-title":"Blood"},{"key":"9052_CR21","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/nmeth.3312","volume":"12","author":"A Chavez","year":"2015","unstructured":"Chavez A, Scheiman J, Vora S, Pruitt BW, Tuttle M, Iyer PR, et al. Highly efficient Cas9-mediated transcriptional programming. Nat Methods. 2015;12:326\u20138.","journal-title":"Nat Methods"},{"key":"9052_CR22","doi-asserted-by":"publisher","first-page":"4992","DOI":"10.1158\/0008-5472.CAN-13-0308","volume":"73","author":"Q Huang","year":"2013","unstructured":"Huang Q, Tan Y, Yin P, Ye G, Gao P, Lu X, et al. Metabolic characterization of hepatocellular carcinoma using nontargeted tissue metabolomics. Cancer Res. 2013;73:4992\u20135002.","journal-title":"Cancer Res"},{"key":"9052_CR23","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1021\/acs.jproteome.9b00185","volume":"18","author":"A Ferrarini","year":"2019","unstructured":"Ferrarini A, Di Poto C, He S, Tu C, Varghese RS, Kara Balla A, et al. Metabolomic analysis of liver tissues for characterization of hepatocellular carcinoma. J Proteome Res. 2019;18:3067\u201376.","journal-title":"J Proteome Res"},{"key":"9052_CR24","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1002\/mc.23455","volume":"61","author":"G Hou","year":"2022","unstructured":"Hou G, Ding D, Tian T, Dong W, Sun D, Liu G, et al. Metabolomics-based classification reveals subtypes of hepatocellular carcinoma. Mol Carcinog. 2022;61:989\u20131001.","journal-title":"Mol Carcinog"},{"key":"9052_CR25","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.cmet.2022.06.010","volume":"34","author":"R Missiaen","year":"2022","unstructured":"Missiaen R, Anderson NM, Kim LC, Nance B, Burrows M, Skuli N, et al. GCN2 inhibition sensitizes arginine-deprived hepatocellular carcinoma cells to senolytic treatment. Cell Metab. 2022;34:1151\u201367.e7.","journal-title":"Cell Metab"},{"key":"9052_CR26","doi-asserted-by":"publisher","first-page":"5068","DOI":"10.1016\/j.cell.2023.09.011","volume":"186","author":"D Mossmann","year":"2023","unstructured":"Mossmann D, Muller C, Park S, Ryback B, Colombi M, Ritter N, et al. Arginine reprograms metabolism in liver cancer via RBM39. Cell. 2023;186:5068\u201383.e23.","journal-title":"Cell"},{"key":"9052_CR27","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/nchembio.2307","volume":"13","author":"AM Intlekofer","year":"2017","unstructured":"Intlekofer AM, Wang B, Liu H, Shah H, Carmona-Fontaine C, Rustenburg AS, et al. L-2-Hydroxyglutarate production arises from noncanonical enzyme function at acidic pH. Nat Chem Biol. 2017;13:494\u2013500.","journal-title":"Nat Chem Biol"},{"key":"9052_CR28","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.cmet.2015.06.023","volume":"22","author":"AM Intlekofer","year":"2015","unstructured":"Intlekofer AM, Dematteo RG, Venneti S, Finley LW, Lu C, Judkins AR, et al. Hypoxia induces production of L-2-hydroxyglutarate. Cell Metab. 2015;22:304\u201311.","journal-title":"Cell Metab"},{"key":"9052_CR29","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.cmet.2015.06.021","volume":"22","author":"WM Oldham","year":"2015","unstructured":"Oldham WM, Clish CB, Yang Y, Loscalzo J. Hypoxia-mediated increases in L-2-hydroxyglutarate coordinate the metabolic response to reductive stress. Cell Metab. 2015;22:291\u2013303.","journal-title":"Cell Metab"},{"key":"9052_CR30","doi-asserted-by":"publisher","first-page":"13005","DOI":"10.1021\/bi001088w","volume":"39","author":"E Mosharov","year":"2000","unstructured":"Mosharov E, Cranford MR, Banerjee R. The quantitatively important relationship between homocysteine metabolism and glutathione synthesis by the transsulfuration pathway and its regulation by redox changes. Biochemistry. 2000;39:13005\u201311.","journal-title":"Biochemistry"},{"key":"9052_CR31","doi-asserted-by":"publisher","first-page":"15878","DOI":"10.1074\/jbc.M114.635144","volume":"290","author":"RR Crawford","year":"2015","unstructured":"Crawford RR, Prescott ET, Sylvester CF, Higdon AN, Shan J, Kilberg MS, et al. Human CHAC1 protein degrades glutathione, and mRNA induction is regulated by the transcription factors ATF4 and ATF3 and a bipartite ATF\/CRE regulatory element. J Biol Chem. 2015;290:15878\u201391.","journal-title":"J Biol Chem"},{"key":"9052_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109706","volume":"36","author":"X Li","year":"2021","unstructured":"Li X, Gracilla D, Cai L, Zhang M, Yu X, Chen X, et al. ATF3 promotes the serine synthesis pathway and tumor growth under dietary serine restriction. Cell Rep. 2021;36:109706.","journal-title":"Cell Rep"},{"key":"9052_CR33","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41418-019-0380-z","volume":"27","author":"L Wang","year":"2020","unstructured":"Wang L, Liu Y, Du T, Yang H, Lei L, Guo M, et al. ATF3 promotes erastin-induced ferroptosis by suppressing system Xc. Cell Death Differ. 2020;27:662\u201375.","journal-title":"Cell Death Differ"},{"key":"9052_CR34","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41420-022-01212-0","volume":"8","author":"T Ma","year":"2022","unstructured":"Ma T, Du J, Zhang Y, Wang Y, Wang B, Zhang T. GPX4-independent ferroptosis-a new strategy in disease\u2019s therapy. Cell Death Discov. 2022;8:434.","journal-title":"Cell Death Discov"},{"key":"9052_CR35","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","volume":"575","author":"S Doll","year":"2019","unstructured":"Doll S, Freitas FP, Shah R, Aldrovandi M, da Silva MC, Ingold I, et al. FSP1 is a glutathione-independent ferroptosis suppressor. Nature. 2019;575:693\u20138.","journal-title":"Nature"},{"key":"9052_CR36","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/s41556-019-0305-6","volume":"21","author":"B Chu","year":"2019","unstructured":"Chu B, Kon N, Chen D, Li T, Liu T, Jiang L, et al. ALOX12 is required for p53-mediated tumour suppression through a distinct ferroptosis pathway. Nat Cell Biol. 2019;21:579\u201391.","journal-title":"Nat Cell Biol"},{"key":"9052_CR37","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41586-021-03539-7","volume":"593","author":"C Mao","year":"2021","unstructured":"Mao C, Liu X, Zhang Y, Lei G, Yan Y, Lee H, et al. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer. Nature. 2021;593:586\u201390.","journal-title":"Nature"},{"key":"9052_CR38","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41586-020-2732-8","volume":"585","author":"Y Zou","year":"2020","unstructured":"Zou Y, Henry WS, Ricq EL, Graham ET, Phadnis VV, Maretich P, et al. Plasticity of ether lipids promotes ferroptosis susceptibility and evasion. Nature. 2020;585:603\u20138.","journal-title":"Nature"},{"key":"9052_CR39","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1016\/j.cell.2023.05.003","volume":"186","author":"D Liang","year":"2023","unstructured":"Liang D, Feng Y, Zandkarimi F, Wang H, Zhang Z, Kim J, et al. Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones. Cell. 2023;186:2748\u201364.e22.","journal-title":"Cell"},{"key":"9052_CR40","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.cell.2017.09.044","volume":"171","author":"SE Wenzel","year":"2017","unstructured":"Wenzel SE, Tyurina YY, Zhao J, St Croix CM, Dar HH, Mao G, et al. PEBP1 wardens ferroptosis by enabling lipoxygenase generation of lipid death signals. Cell. 2017;171:628\u201341.e26.","journal-title":"Cell"},{"key":"9052_CR41","doi-asserted-by":"crossref","unstructured":"Ma S, Sun R, Jiang B, Gao J, Deng W, Liu P, et al. L2hgdh deficiency accumulates l-2-hydroxyglutarate with progressive leukoencephalopathy and neurodegeneration. Mol Cell Biol. 2017;37:e00492-16.","DOI":"10.1128\/MCB.00492-16"},{"key":"9052_CR42","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1038\/s41388-023-02632-7","volume":"42","author":"S Tabata","year":"2023","unstructured":"Tabata S, Kojima Y, Sakamoto T, Igarashi K, Umetsu K, Ishikawa T, et al. L-2hydroxyglutaric acid rewires amino acid metabolism in colorectal cancer via the mTOR-ATF4 axis. Oncogene. 2023;42:1294\u2013307.","journal-title":"Oncogene"},{"key":"9052_CR43","doi-asserted-by":"crossref","unstructured":"Kundu A, Brinkley GJ, Nam H, Karki S, Kirkman R, Pandit M, et al. l-2-Hydroxyglutarate remodeling of the epigenome and epitranscriptome creates a metabolic vulnerability in kidney cancer models. J Clin Invest. 2024;134:e171294.","DOI":"10.1172\/JCI171294"},{"key":"9052_CR44","doi-asserted-by":"publisher","first-page":"6433","DOI":"10.1158\/1078-0432.CCR-18-1727","volume":"24","author":"S Shelar","year":"2018","unstructured":"Shelar S, Shim EH, Brinkley GJ, Kundu A, Carobbio F, Poston T, et al. Biochemical and epigenetic insights into L-2-hydroxyglutarate, a potential therapeutic target in renal cancer. Clin Cancer Res. 2018;24:6433\u201346.","journal-title":"Clin Cancer Res"},{"key":"9052_CR45","doi-asserted-by":"crossref","unstructured":"Gu W, Wang X, Solmonson A, Cai L, Xiao Y, Tasdogan A, et al. L-2-hydroxyglutarate impairs neuronal differentiation through epigenetic activation of MYC expression. bioRxiv. 2025. 2025.04.16.649033.","DOI":"10.1101\/2025.04.16.649033"},{"key":"9052_CR46","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.chembiol.2020.02.002","volume":"27","author":"Z Qiu","year":"2020","unstructured":"Qiu Z, Lin AP, Jiang S, Elkashef SM, Myers J, Srikantan S, et al. MYC Regulation of D2HGDH and L2HGDH influences the epigenome and epitranscriptome. Cell Chem Biol. 2020;27:538\u201350.e7.","journal-title":"Cell Chem Biol"},{"key":"9052_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1984-4","volume":"10","author":"TX Wang","year":"2019","unstructured":"Wang TX, Liang JY, Zhang C, Xiong Y, Guan KL, Yuan HX. The oncometabolite 2-hydroxyglutarate produced by mutant IDH1 sensitizes cells to ferroptosis. Cell Death Dis. 2019;10:755.","journal-title":"Cell Death Dis"},{"key":"9052_CR48","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.cell.2017.11.031","volume":"172","author":"R Su","year":"2018","unstructured":"Su R, Dong L, Li C, Nachtergaele S, Wunderlich M, Qing Y, et al. R-2HG exhibits anti-tumor activity by targeting FTO\/m(6)A\/MYC\/CEBPA signaling. Cell. 2018;172:90\u2013105.e23.","journal-title":"Cell"},{"key":"9052_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49202-3","volume":"15","author":"R Li","year":"2024","unstructured":"Li R, Yan X, Xiao C, Wang T, Li X, Hu Z, et al. FTO deficiency in older livers exacerbates ferroptosis during ischaemia\/reperfusion injury by upregulating ACSL4 and TFRC. Nat Commun. 2024;15:4760.","journal-title":"Nat Commun"},{"key":"9052_CR50","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13046-024-03032-9","volume":"43","author":"Y Qiao","year":"2024","unstructured":"Qiao Y, Su M, Zhao H, Liu H, Wang C, Dai X, et al. Targeting FTO induces colorectal cancer ferroptotic cell death by decreasing SLC7A11\/GPX4 expression. J Exp Clin Cancer Res. 2024;43:108.","journal-title":"J Exp Clin Cancer Res"},{"key":"9052_CR51","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/s41556-021-00637-6","volume":"23","author":"J Andrade","year":"2021","unstructured":"Andrade J, Shi C, Costa ASH, Choi J, Kim J, Doddaballapur A, et al. Control of endothelial quiescence by FOXO-regulated metabolites. Nat Cell Biol. 2021;23:413\u201323.","journal-title":"Nat Cell Biol"},{"key":"9052_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107437","volume":"209","author":"J Hao","year":"2024","unstructured":"Hao J, Huang Z, Zhang S, Song K, Wang J, Gao C, et al. Deciphering the multifaceted roles and clinical implications of 2-hydroxyglutarate in cancer. Pharm Res. 2024;209:107437.","journal-title":"Pharm Res"},{"key":"9052_CR53","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1089\/ars.2019.7902","volume":"33","author":"P Jezek","year":"2020","unstructured":"Jezek P. 2-Hydroxyglutarate in cancer cells. Antioxid Redox Signal. 2020;33:903\u201326.","journal-title":"Antioxid Redox Signal"},{"key":"9052_CR54","doi-asserted-by":"crossref","unstructured":"Yang Y, Li X, Liu F, Ma M, Yang Y, Ruan C, et al. Immunometabolite L-2-HG promotes epigenetic modification of exhausted T cells and improves antitumor immunity. JCI Insight. 2025;10:e174600.","DOI":"10.1172\/jci.insight.174600"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09052-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09052-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09052-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:02:11Z","timestamp":1790892131000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09052-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9052"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-09052-x","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"28 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All patient Liver and tumor tissues were obtained written informed consent, provided by the UC Davis Health Biorepository Shared Resource under a protocol approved by the Institutional Review Board of Augusta University (protocol #1566594-1). The authors had no access to identifiable patient information. All methods were performed in accordance with the relevant guidelines and regulations, in agreement with the Declaration of Helsinki. All animal procedures were conducted in accordance with federal ethical guidelines and were approved by the Institutional Animal Care and Use Committee of Augusta University (protocol #2019-1010).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"850"}}